chr1-27382506-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001330448.1(CD164L2):c.250G>A(p.Glu84Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000317 in 1,602,472 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 2 hom. )
Consequence
CD164L2
NM_001330448.1 missense
NM_001330448.1 missense
Scores
10
9
Clinical Significance
Conservation
PhyloP100: 3.99
Genes affected
CD164L2 (HGNC:32043): (CD164 molecule like 2) Predicted to be integral component of membrane. Predicted to be active in cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.02282244).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD164L2 | NM_001330448.1 | c.250G>A | p.Glu84Lys | missense_variant | 2/6 | ENST00000374030.3 | NP_001317377.1 | |
CD164L2 | NM_207397.5 | c.250G>A | p.Glu84Lys | missense_variant | 2/5 | NP_997280.2 | ||
CD164L2 | XM_011541441.2 | c.250G>A | p.Glu84Lys | missense_variant | 2/6 | XP_011539743.1 | ||
CD164L2 | XR_241190.4 | n.344G>A | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD164L2 | ENST00000374030.3 | c.250G>A | p.Glu84Lys | missense_variant | 2/6 | 5 | NM_001330448.1 | ENSP00000363142.1 | ||
CD164L2 | ENST00000374027.7 | c.250G>A | p.Glu84Lys | missense_variant | 2/5 | 1 | ENSP00000363139.3 | |||
CD164L2 | ENST00000374025.4 | n.317G>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152086Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
49
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000486 AC: 119AN: 244800Hom.: 2 AF XY: 0.000470 AC XY: 62AN XY: 132040
GnomAD3 exomes
AF:
AC:
119
AN:
244800
Hom.:
AF XY:
AC XY:
62
AN XY:
132040
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000316 AC: 459AN: 1450386Hom.: 2 Cov.: 31 AF XY: 0.000325 AC XY: 234AN XY: 719858
GnomAD4 exome
AF:
AC:
459
AN:
1450386
Hom.:
Cov.:
31
AF XY:
AC XY:
234
AN XY:
719858
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000322 AC: 49AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.000310 AC XY: 23AN XY: 74282
GnomAD4 genome
AF:
AC:
49
AN:
152086
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
52
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2021 | The c.250G>A (p.E84K) alteration is located in exon 2 (coding exon 2) of the CD164L2 gene. This alteration results from a G to A substitution at nucleotide position 250, causing the glutamic acid (E) at amino acid position 84 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
T;T
Polyphen
1.0
.;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at